| 1/1 | US=50 / Câncer Hauschild A, Kahler KC, Egberts F. Sorafenib, a multikinase inhibitor: results from clinical trials in melanoma patients. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 565-74. ISBN 978-1-60327-086-1. SORAFENIB. INIBIDOR MULTIQUINASE; PACIENTES COM MELANOMA; MELANOMA; METASTASE; SORAFENIB; INIBIDORES MULTIQUINASE |